Skip to main content
SpringerLink
Log in

Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol

  • Research Article
  • Published:
Tumor Biology

Abstract

The BCL2 family of proteins includes apoptosis-related molecules involved in normal physiology, as well as cancer pathology. Members of our team have discovered and cloned the novel gene BCL2L12, which codes for a protein member of the BCL2 family. The BCL2L12 expression has been studied extensively in various types of cancer and its important clinical value has been underlined. The main objective of this study is the relative quantification of the mRNA expression of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric cancer cells, following treatment with anticancer drugs. Gastric adenocarcinoma cells AGS were treated with various concentrations of the chemical substances cisplatin, etoposide and taxol for three time periods. Cell viability was examined by using the MTT assay. Total RNA was extracted and reverse transcribed into cDNA. A highly sensitive, quantitative real-time PCR method was developed based on the SYBR Green chemistry, for the proper mRNA quantification. GAPDH was used as a housekeeping gene. Relative quantification analysis was performed by using the comparative CT method (\( 2^{−{\text{DDC}}_{\text{T}}} \)). Treatment of AGS cells with 10 μM cisplatin, 0.5 μM etoposide and 10 nM taxol affected the BCL2, BAX and BCL2L12 mRNA levels, compared to the untreated cells. Cisplatin and etoposide induced a major down-regulation in the BCL2 mRNA levels after 72 h of treatment, while the BAX mRNA levels were slightly up-regulated. Moreover, taxol had an up-regulating effect on both BCL2 and BAX transcript levels after 48 h of incubation. Chemotherapy had a much smaller effect on the BCL2L12 expression levels, eventually characterised by a small down-regulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

BCL2:

B-cell CLL/lymphoma 2

BCL2L12 :

BCL2 like gene 12

BH domain:

BCL2 homology domains

CA 19-9:

Carbohydrate antigen 19-9

CA 72-4:

Cancer antigen 72-4

CEA:

Carcinoembryonic antigen

CLL:

Chronic lymphocytic leukaemia

DFS:

Disease-free survival

H. pylori :

Helicobacter pylori

IRF3 :

Interferon regulatory factor 3 gene

PRMT1/HRMT1L2 :

Protein arginine methyltransferase 1 gene

SSCP:

Single-strand conformation polymorphism

References

  1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–57.

    Article  PubMed  CAS  Google Scholar 

  2. Thomadaki H, Scorilas A. Bcl2 family of apoptosis-related genes: functions and clinical implications in cancer. Crit Rev Clin Lab Sci. 2006;43:1–67.

    Article  PubMed  CAS  Google Scholar 

  3. Petros AM, Olejniczak ET, Fesik SW. Structural biology of the bcl-2 family of proteins. Biochim Biophys Acta. 2004;1644:83–94.

    Article  PubMed  CAS  Google Scholar 

  4. Adams JM, Cory S. The bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322–6.

    Article  PubMed  CAS  Google Scholar 

  5. Hanada M, Aime-Sempe C, Sato T, Reed JC. Structure–function analysis of bcl-2 protein. Identification of conserved domains important for homodimerization with bcl-2 and heterodimerization with bax. J Biol Chem. 1995;270:11962–9.

    Article  PubMed  CAS  Google Scholar 

  6. Zivny J, Klener Jr P. Pytlik R, Andera L: The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies. Curr Pharm Des. 2010;16:11–33.

    Article  PubMed  CAS  Google Scholar 

  7. Kirkin V, Joos S, Zornig M. The role of bcl-2 family members in tumorigenesis. Biochim Biophys Acta. 2004;1644:229–49.

    Article  PubMed  CAS  Google Scholar 

  8. Apte SS, Mattei MG, Olsen BR. Mapping of the human bax gene to chromosome 19q13.3-q13.4 and isolation of a novel alternatively spliced transcript, bax delta. Genomics. 1995;26:592–4.

    Article  PubMed  CAS  Google Scholar 

  9. Oltvai ZN, Korsmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell. 1994;79:189–92.

    Article  PubMed  CAS  Google Scholar 

  10. Scorilas A, Kyriakopoulou L, Yousef GM, Ashworth LK, Kwamie A, Diamandis EP. Molecular cloning, physical mapping, and expression analysis of a novel gene, bcl2l12, encoding a proline-rich protein with a highly conserved bh2 domain of the bcl-2 family. Genomics. 2001;72:217–21.

    Article  PubMed  CAS  Google Scholar 

  11. Fenogilo-Preiser C, Carneiro F, Correa P. Gastric carcinoma. In: Hamilton S, Aaltonin L, editors. Pathology and genetics tumors of the digestive system, vol 1. Lyon: Lyon Press; 2000.

    Google Scholar 

  12. Partridge M, Gaballah K, Huang X. Molecular markers for diagnosis and prognosis. Cancer Metastasis Rev. 2005;24:71–85.

    Article  PubMed  CAS  Google Scholar 

  13. Schwartz GK. Invasion and metastases in gastric cancer: in vitro and in vivo models with clinical correlations. Semin Oncol. 1996;23:316–24.

    PubMed  CAS  Google Scholar 

  14. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol. 2009;71:127–64.

    Article  PubMed  Google Scholar 

  15. Ebert MP, Rocken C. Molecular screening of gastric cancer by proteome analysis. Eur J Gastroenterol Hepatol. 2006;18:847–53.

    Article  PubMed  CAS  Google Scholar 

  16. Strasser A, Harris AW, Bath ML, Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 1990;348:331–3.

    Article  PubMed  CAS  Google Scholar 

  17. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309–12.

    Article  PubMed  CAS  Google Scholar 

  18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.

    Article  PubMed  CAS  Google Scholar 

  19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta c(t)) method. Methods. 2001;25:402–8.

    Article  PubMed  CAS  Google Scholar 

  20. Katsumata M, Siegel RM, Louie DC, Miyashita T, Tsujimoto Y, Nowell PC, et al. Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci USA. 1992;89:11376–80.

    Article  PubMed  CAS  Google Scholar 

  21. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, et al. Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 1989;57:79–88.

    Article  PubMed  CAS  Google Scholar 

  22. Bairey O, Zimra Y, Shaklai M, Okon E, Rabizadeh E. Bcl-2, Bcl-x, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas. Clin Cancer Res. 1999;5:2860–6.

    PubMed  CAS  Google Scholar 

  23. Binder C, Marx D, Overhoff R, Binder L, Schauer A, Hiddemann W. Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables. Ann Oncol. 1995;6:1005–10.

    PubMed  CAS  Google Scholar 

  24. Campana D, Coustan-Smith E, Manabe A, Buschle M, Raimondi SC, Behm FG, et al. Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein. Blood. 1993;81:1025–31.

    PubMed  CAS  Google Scholar 

  25. Campos L, Sabido O, Sebban C, Charrin C, Bertheas MF, Fiere D, et al. Expression of bcl-2 proto-oncogene in adult acute lymphoblastic leukemia. Leukemia. 1996;10:434–8.

    PubMed  CAS  Google Scholar 

  26. Flohil CC, Janssen PA, Bosman FT. Expression of bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon. J Pathol. 1996;178:393–7.

    Article  PubMed  CAS  Google Scholar 

  27. Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi M, Angeletti CA, et al. Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer. 1995;71:1003–7.

    Article  PubMed  CAS  Google Scholar 

  28. Karakas T, Maurer U, Weidmann E, Miething CC, Hoelzer D, Bergmann L. High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia. Ann Oncol. 1998;9:159–65.

    Article  PubMed  CAS  Google Scholar 

  29. Laudanski J, Chyczewski L, Niklinska WE, Kretowska M, Furman M, Sawicki B, et al. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival. Neoplasma. 1999;46:25–30.

    PubMed  CAS  Google Scholar 

  30. Ramsay JA, From L, Kahn HJ. Bcl-2 protein expression in melanocytic neoplasms of the skin. Mod Pathol. 1995;8:150–4.

    PubMed  CAS  Google Scholar 

  31. Schorr K, Li M, Krajewski S, Reed JC, Furth PA. Bcl-2 gene family and related proteins in mammary gland involution and breast cancer. J Mammary Gland Biol Neoplasia. 1999;4:153–64.

    Article  PubMed  CAS  Google Scholar 

  32. Tsuji M, Murakami Y, Kanayama H, Sano T, Kagawa S. Immunohistochemical analysis of Ki-67 antigen and Bcl-2 protein expression in prostate cancer: effect of neoadjuvant hormonal therapy. Br J Urol. 1998;81:116–21.

    Article  PubMed  CAS  Google Scholar 

  33. Konturek PC, Konturek SJ, Sulekova Z, Meixner H, Bielanski W, Starzynska T, et al. Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl-2, and gastrin in human gastric cancer. Aliment Pharmacol Ther. 2001;15:989–99.

    Article  PubMed  CAS  Google Scholar 

  34. Krajewska M, Fenoglio-Preiser CM, Krajewski S, Song K, Macdonald JS, Stemmerman G, et al. Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am J Pathol. 1996;149:1449–57.

    PubMed  CAS  Google Scholar 

  35. Lauwers GY, Scott GV, Karpeh MS. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer. 1995;75:2209–13.

    Article  PubMed  CAS  Google Scholar 

  36. Panani AD. Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett. 2008;266:99–115.

    Article  PubMed  CAS  Google Scholar 

  37. Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer. 2003;97:545–53.

    Article  PubMed  Google Scholar 

  38. Richardson A, Kaye SB. Pharmacological inhibition of the bcl-2 family of apoptosis regulators as cancer therapy. Curr Mol Pharmacol. 2008;1:244–54.

    Article  PubMed  CAS  Google Scholar 

  39. Thomadaki H, Scorilas A. Molecular profile of the bcl2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic/cytostatic drugs. Connect Tissue Res. 2008;49:261–4.

    Article  PubMed  CAS  Google Scholar 

  40. Floros KV, Talieri M, Scorilas A. Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells. Biol Chem. 2006;387:1629–33.

    Article  PubMed  CAS  Google Scholar 

  41. Floros KV, Thomadaki H, Katsaros N, Talieri M, Scorilas A. mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biol Chem. 2004;385:1099–103.

    Article  PubMed  CAS  Google Scholar 

  42. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer. 2002;2:594–604.

    Article  PubMed  CAS  Google Scholar 

  43. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004;303:1010–4.

    Article  PubMed  CAS  Google Scholar 

  44. Kaneuchi M, Yamashita T, Shindoh M, Segawa K, Takahashi S, Furuta I, et al. Induction of apoptosis by the p53-273l (Arg → Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax. Mol Carcinog. 1999;26:44–52.

    Article  PubMed  CAS  Google Scholar 

  45. Salah-eldin A, Inoue S, Tsuda M, Matsuura A. Abnormal intracellular localization of Bax with a normal membrane anchor domain in human lung cancer cell lines. Jpn J Cancer Res. 2000;91:1269–77.

    Article  PubMed  CAS  Google Scholar 

  46. Sturm I, Papadopoulos S, Hillebrand T, Benter T, Luck HJ, Wolff G, et al. Impaired BAX protein expression in breast cancer: mutational analysis of the BAX and the p53 gene. Int J Cancer. 2000;87:517–21.

    Article  PubMed  CAS  Google Scholar 

  47. Gil J, Yamamoto H, Zapata JM, Reed JC, Perucho M. Impairment of the proapoptotic activity of Bax by missense mutations found in gastrointestinal cancers. Cancer Res. 1999;59:2034–7.

    PubMed  CAS  Google Scholar 

  48. Komatsu K, Suzuki S, Shimosegawa T, Miyazaki JI, Toyota T. Cre-loxP-mediated bax gene activation reduces growth rate and increases sensitivity to chemotherapeutic agents in human gastric cancer cells. Cancer Gene Ther. 2000;7:885–92.

    Article  PubMed  CAS  Google Scholar 

  49. Floros KV, Thomadaki H, Florou D, Talieri M, Scorilas A. Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide. Ann N Y Acad Sci. 2006;1090:89–97.

    Article  PubMed  CAS  Google Scholar 

  50. Stegh AH, Chin L, Louis DN, DePinho RA. What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2l12 as a multifunctional cell death regulator. Cell Cycle. 2008;7:2833–9.

    Article  PubMed  CAS  Google Scholar 

  51. Stegh AH, Kesari S, Mahoney JE, Jenq HT, Forloney KL, Protopopov A, et al. Bcl2l12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma. Proc Natl Acad Sci USA. 2008;105:10703–8.

    Article  PubMed  CAS  Google Scholar 

  52. Stegh AH, Kim H, Bachoo RM, Forloney KL, Zhang J, Schulze H, et al. Bcl2l12 inhibits post-mitochondrial apoptosis signaling in glioblastoma. Genes Dev. 2007;21:98–111.

    Article  PubMed  CAS  Google Scholar 

  53. Stegh AH, Brennan C, Mahoney JA, Forloney KL, Jenq HT, Luciano JP, et al. Glioma oncoprotein bcl2l12 inhibits the p53 tumor suppressor. Genes Dev. 2010;24:2194–204.

    Article  PubMed  CAS  Google Scholar 

  54. Nakajima A, Nishimura K, Nakaima Y, Oh T, Noguchi S, Taniguchi T, et al. Cell type-dependent proapoptotic role of bcl2l12 revealed by a mutation concomitant with the disruption of the juxtaposed irf3 gene. Proc Natl Acad Sci USA. 2009;106:12448–52.

    Article  PubMed  CAS  Google Scholar 

  55. Hong Y, Yang J, Wu W, Wang W, Kong X, Wang Y, et al. Knockdown of BCL2L12 leads to cisplatin resistance in MDA-MB-231 breast cancer cells. Biochim Biophys Acta. 2008;1782:649–57.

    PubMed  CAS  Google Scholar 

  56. Hong Y, Yang J, Chi Y, Wang W, Wu W, Yun X, et al. BCL2L12A localizes to the cell nucleus and induces growth inhibition through G2/M arrest in CHO cells. Mol Cell Biochem. 2010;333:323–30.

    Article  PubMed  CAS  Google Scholar 

  57. Talieri M, Diamandis EP, Katsaros N, Gourgiotis D, Scorilas A. Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors. Thromb Haemost. 2003;89:1081–8.

    PubMed  CAS  Google Scholar 

  58. Thomadaki H, Talieri M, Scorilas A. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer. Cancer Lett. 2007;247:48–55.

    Article  PubMed  CAS  Google Scholar 

  59. Mathioudaki K, Scorilas A, Papadokostopoulou A, Xynopoulos D, Arnogianaki N, Agnanti N, et al. Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer. Biol Chem. 2004;385:779–83.

    Article  PubMed  CAS  Google Scholar 

  60. Kontos CK, Papadopoulos IN, Scorilas A. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer. Biol Chem. 2008;389:1467–75.

    Article  PubMed  CAS  Google Scholar 

  61. Papageorgiou SG, Kontos CK, Pappa V, Thomadaki H, Kontsioti F, Dervenoulas J, et al. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker. Oncologist. 2011;16:1280–91.

    Article  PubMed  CAS  Google Scholar 

  62. Fendri A, Kontos CK, Khabir A, Mokdad-Gargouri R, Scorilas A. BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma. Mol Med. 2011;17:163–71.

    Article  PubMed  CAS  Google Scholar 

  63. Florou D, Papadopoulos IN, Scorilas A. Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer. Biochem Biophys Res Commun. 2010;391:214–8.

    Article  PubMed  CAS  Google Scholar 

  64. Floros KV, Thomadaki H, Lallas G, Katsaros N, Talieri M, Scorilas A. Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells: differential expression of BCL2 and novel apoptosis-related gene BCL2L12. Ann N Y Acad Sci. 2003;1010:153–8.

    Article  PubMed  CAS  Google Scholar 

  65. Thomadaki H, Floros KV, Scorilas A. Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12. Ann N Y Acad Sci. 2009;1171:276–83.

    Article  PubMed  CAS  Google Scholar 

  66. Thomadaki H, Scorilas A. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. Ann N Y Acad Sci. 2007;1095:35–44.

    Article  PubMed  CAS  Google Scholar 

  67. Thomadaki H, Talieri M, Scorilas A. Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS. Biol Chem. 2006;387:1081–6.

    Article  PubMed  CAS  Google Scholar 

  68. Thomadaki H, Scorilas A. Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol. Biol Chem. 2008;389:1427–34.

    Article  PubMed  CAS  Google Scholar 

  69. Zhuo Z, Zhang L, Mu Q, Lou Y, Gong Z, Shi Y, et al. The effect of combination treatment with docosahexaenoic acid and 5-fluorouracil on the mRNA expression of apoptosis-related genes, including the novel gene BCL2L12, in gastric cancer cells. In Vitro Cell Dev Biol Anim. 2009;45:69–74.

    Article  PubMed  CAS  Google Scholar 

  70. Korbakis D, Scorilas A. Treatment of gastric cancer cells with 5-fluorouracil/leucovorin and irinotecan induces distinct alterations in the mRNA expression of the apoptosis-related genes, including the novel gene BCL2L12. Tumour Biol. 2009;30:100–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The project was supported by a PENED grant co-funded by the European Union–European Social Funds (75% from the European Union), National Resources (25% from governmental funds)–Ministry of Development–General Secretariat for Research & Technology of Greece and ELPEN A.E. through EPAN.M.8.3—3rd Community Support Programme.

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Panepistimiopolis, 15701, Athens, Greece

    Dimitrios Korbakis & Andreas Scorilas

Authors
  1. Dimitrios Korbakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andreas Scorilas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Scorilas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Korbakis, D., Scorilas, A. Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol. Tumor Biol. 33, 865–875 (2012). https://doi.org/10.1007/s13277-011-0313-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-011-0313-z

Keywords

Search

Navigation